Intercontinental Exchange, Inc.
Jeffrey C Sprecher (Chief Executive Officer) sells ICE shares
AI-generated summary
Jeffrey C Sprecher, Chief Executive Officer, Director of Intercontinental Exchange, Inc., exercised options to acquire 34,923 shares for $2,367,495.77, gifted 28,090 shares, and sold 183,844 shares at an average price of $174.07 for a total of $32,002,154.90 under a Rule 10b5-1 trading plan adopted on August 18, 2026. Following these transactions, the insider holds 1,501,705 shares indirectly through CPEX.
Key facts
- Insider
- Jeffrey C Sprecher · Chief Executive Officer, Director
Rule 10b5-1 plan
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Nov 17, 2026 | M · exercise or conversion of a derivativeFootnotes F1, F2 | +33,844 | $67.00 | $2,267,548.00 | 1,128,868 | Direct |
| Nov 17, 2026 | M · exercise or conversion of a derivativeFootnotes F1 | +1,079 | $92.63 | $99,947.77 | 1,129,947 | Direct |
| Nov 17, 2026 | G · giftFootnotes F3 | −28,090 | $0.00 | $0.00 | 1,101,857 | Direct |
| Nov 17, 2026 | S · open-market saleFootnotes F1, F4 | −12,940 | $172.30 | $2,229,545.18 | 1,088,917 | Direct |
| Nov 17, 2026 | S · open-market saleFootnotes F1, F5 | −3,944 | $173.28 | $683,416.71 | 1,084,973 | Direct |
| Nov 17, 2026 | S · open-market saleFootnotes F1, F6 | −3,479 | $174.40 | $606,734.12 | 1,081,494 | Direct |
| Nov 17, 2026 | S · open-market saleFootnotes F1, F7 | −8,040 | $175.51 | $1,411,077.89 | 1,073,454 | Direct |
| Nov 17, 2026 | S · open-market saleFootnotes F1, F8 | −4,745 | $176.45 | $837,259.99 | 1,068,709 | Direct |
| Nov 17, 2026 | S · open-market saleFootnotes F1, F9, F10, F11, F12 | −696 | $177.14 | $123,286.03 | 1,068,013 | Direct |
| Nov 17, 2026 | S · open-market saleFootnotes F1, F4 | −57,377 | $172.30 | $9,885,976.77 | 1,594,328 | Indirect (CPEX) |
| Nov 17, 2026 | S · open-market saleFootnotes F1, F5 | −17,500 | $173.28 | $3,032,403.50 | 1,576,828 | Indirect (CPEX) |
| Nov 17, 2026 | S · open-market saleFootnotes F1, F6 | −15,390 | $174.40 | $2,683,977.52 | 1,561,438 | Indirect (CPEX) |
| Nov 17, 2026 | S · open-market saleFootnotes F1, F7 | −35,611 | $175.51 | $6,250,015.39 | 1,525,827 | Indirect (CPEX) |
| Nov 17, 2026 | S · open-market saleFootnotes F1, F8 | −21,034 | $176.45 | $3,711,466.13 | 1,504,793 | Indirect (CPEX) |
| Nov 17, 2026 | S · open-market saleFootnotes F1, F9, F13 | −3,088 | $177.14 | $546,995.66 | 1,501,705 | Indirect (CPEX) |
| Nov 17, 2026 | M · exercise or conversion of a derivativeEmployee Stock Option (right to buy) HoldingFootnotes F15 | −33,844 | $0.00 | $0.00 | 67,689 | Direct |
| Nov 17, 2026 | M · exercise or conversion of a derivativeEmployee Stock Option (right to buy) HoldingFootnotes F15 | −1,079 | $0.00 | $0.00 | 128,026 | Direct |
Footnotes
- F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of August 18, 2026.
- F2 Amount of securities beneficially owned includes 101 shares acquired under Intercontinental Exchange, Inc. Employee Stock Purchase Plan on June 30, 2026.
- F3 This transaction involved a gift of 28,090 shares of the issuer's common stock by the reporting person to a philanthropic organization.
- F4 The price range for the aggregate amount sold by the direct holder is $171.98 - $172.97. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
- F5 The price range for the aggregate amount sold by the direct holder is $172.98 - $173.97. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
- F6 The price range for the aggregate amount sold by the direct holder is $173.98 - $174.95. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
- F7 The price range for the aggregate amount sold by the direct holder is $174.98 - $175.97. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
- F8 The price range for the aggregate amount sold by the direct holder is $175.98 - $176.97. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
- F9 The price range for the aggregate amount sold by the direct holder is $176.99 - $177.35. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
- F10 The common stock number referred in Table I is an aggregate number and represents 1,007,733 shares of common stock and 46,016 unvested restricted stock units ("RSUs"), and 14,264 performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year.
- F11 The satisfaction of the 2024, 2025 and 2026 TSR PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. The satisfaction of the 2024, 2025 and 2026 three-year earnings before interest, taxes, depreciation, and amortization ("EBITDA") PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting.
- F12 The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period.
- F13 As previously reported, the reporting person also indirectly owns 1,501,705 shares that are beneficially owned directly by CPEX. The reporting person beneficially owns 100% of the equity interest in CPEX. Additionally, as previously reported, the reporting person indirectly owns shares that are beneficially owned directly by the reporting person's spouse for which the reporting person disclaims beneficial ownership.
- F14 As previously reported, the reporting person also indirectly owns 81,570 shares that are beneficially owned directly by the reporting person's spouse for which the reporting person disclaims beneficial ownership.
- F15 These options are fully vested.
More ICE filings
- 144
Filed Nov 19, 2026
- 144
Filed Nov 17, 2026
- 144
Filed Nov 17, 2026
- 4
Filed Nov 13, 2026
- 4
Filed Nov 12, 2026
- 4
Filed Nov 12, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.